The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 1
Abstract
Background. It has been suggested that DM may reduce survival of patients with liver cirrhosis (LC). Nevertheless only few prospective studies assessing the impact of DM on mortality of cirrhotic patients have been published, none in compensated LC. Aims. (i) to study the impact of DM on mortality and (ii) to identify predictors of death. Methods. Patients with compensated LC with and without DM were studied. Survival was analyzed by the Kaplan-Meier Method. Univariate and multivariate analysis was performed to determine independent predictors of mortality. Results. 110 patients were included: 60 without DM and 50 with DM. Diabetic patients had significantly higher frequency of cryptogenic cirrhosis, anemia, hypoalbuminemia, and hypercreatininemia. They also had significantly higher BMI and Child-Pugh score. The 2.5-years cumulative survival was significantly lower in patients with DM (48 vs. 69%, p < 0.05). By univariate analysis: DM, female gender, serum creatinine > 1.5 mg/dL, Child-Pugh score class C and cryptogenic cirrhosis were significant. However, only serum creatinine > 1.5 mg/dL and Child-Pugh score class C were independent predictors of death. Conclusion: DM was associated with a significant increase in mortality in patients with compensated liver cirrhosis. Serum creatinine > 1.5 mg/dL and Child-Pugh score class C were independent predictors of death.
Authors and Affiliations
Joel Omar Jáquez Quintana, Diego García-Compean, Jose Alberto González González, Jesús Zacarías Villarreal Pérez, Fernando Lavalle González, Linda Muñoz Espinosa, Pedro López Hernández, Erick Reyes Cabello, Edgar Redondo Villarreal, Ricardo Flores Rendón, Héctor Maldonado Garza
Keywords
Related Articles
- EP ID EP78005
- DOI -
- Views 132
- Downloads 0
Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis
Background. Diagnosis of progressive familial intrahepatic cholestasis (PFIC) is a challenging matter that involves the summation of clinical, laboratory, radiological, and liver histological parameters; in addition to...
Intestinal mucosal proliferation, apoptosis and oxidative stress in patients with liver cirrhosis
[b]Background[/b]. Intestinal mucosal barrier dysfunction in liver cirrhosis and its implicated mechanisms is of great clinical importance because it is associated with the development of serious complications from diver...
Joint Society statement for elimination of viral hepatitis
Raloxifene hydrochloride as hepatitis C treatment
Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype.